March 08, 2023
Above and beyond: Our research returns to space >
New Approaches to Multiple Myeloma
December 09, 2022
Our bold vision for multiple myeloma >
November 17, 2022
Exploring multiple paths to advance BCMA-targeted therapies >
Jinyi Zhu
October 05, 2022
Crystallizing exponential possibilities in protein degradation >
Julie Meade, PhD, scientific writer, Global Scientific and Regulatory Documentation, collaborates with colleagues in her role at Bristol Myers Squibb
September 29, 2022
Voices from R&D: personal experience inspires the development of new medicines >
August 16, 2022
From numbers to knowledge: Unlocking the predictive power of data to accelerate transformative science >
Today’s cell therapy insights shaping tomorrow
July 20, 2022
Today’s cell therapy insights shaping tomorrow >
Healthcare professionals
March 31, 2022
The quest to stop cancer from coming back  >
Early development center to open in Cambridge Crossing
March 03, 2022
New state-of-the-art research and early development center to open in Cambridge Crossing >
Bristol Myers Squibb’s Thomas O. Daniel Research Incubator and Collaboration Center
February 14, 2022
Unleashing innovation through incubators and beyond >
CD47 embedded in the cell membrane
December 07, 2021
Pulling back the curtain on CD47 >
November 11, 2021
It’s not all smiles in drug development >